These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34769207)

  • 21. miRNA-192 and -215 activate Wnt/β-catenin signaling pathway in gastric cancer via APC.
    Deng S; Zhang X; Qin Y; Chen W; Fan H; Feng X; Wang J; Yan R; Zhao Y; Cheng Y; Wei Y; Fan X; Ashktorab H; Smoot D; Meltzer SJ; Li S; Li K; Peng Y; Jin Z
    J Cell Physiol; 2020 Sep; 235(9):6218-6229. PubMed ID: 32091625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACTH-independent Cushing's syndrome with bilateral micronodular adrenal hyperplasia and ectopic adrenocortical adenoma.
    Louiset E; Gobet F; Libé R; Horvath A; Renouf S; Cariou J; Rothenbuhler A; Bertherat J; Clauser E; Grise P; Stratakis CA; Kuhn JM; Lefebvre H
    J Clin Endocrinol Metab; 2010 Jan; 95(1):18-24. PubMed ID: 19915020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics of Cushing's syndrome.
    Yaneva M; Vandeva S; Zacharieva S; Daly AF; Beckers A
    Neuroendocrinology; 2010; 92 Suppl 1():6-10. PubMed ID: 20829611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The genetics of adrenocortical tumors.
    Espiard S; Bertherat J
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):311-34. PubMed ID: 26038203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism.
    Kamilaris CDC; Stratakis CA; Hannah-Shmouni F
    Front Endocrinol (Lausanne); 2021; 12():632543. PubMed ID: 33776926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of CYP17 and CYP11B1 in subclinical Cushing's syndrome due to adrenal adenomas.
    Cao C; Yang X; Li L; Sun R; Xian Y; Lv W; Wang J; Xu Y; Gao Y
    Int J Urol; 2011 Oct; 18(10):691-6. PubMed ID: 21848792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miRNA-203 Modulates Aldosterone Levels and Cell Proliferation by Targeting Wnt5a in Aldosterone-Producing Adenomas.
    Peng KY; Chang HM; Lin YF; Chan CK; Chang CH; Chueh SJ; Yang SY; Huang KH; Lin YH; Wu VC; Wu KD
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3737-3747. PubMed ID: 30085132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
    Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of circulating extracellular vesicle-associated microRNAs in cortisol-producing adrenocortical tumors.
    Perge P; Decmann Á; Pezzani R; Bancos I; Fassina A; Luconi M; Canu L; Tóth M; Boscaro M; Patócs A; Igaz P
    Endocrine; 2018 Feb; 59(2):280-287. PubMed ID: 29299796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic Causes of Functional Adrenocortical Adenomas.
    Zennaro MC; Boulkroun S; Fernandes-Rosa F
    Endocr Rev; 2017 Dec; 38(6):516-537. PubMed ID: 28973103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal models of adrenocortical tumorigenesis.
    Galac S; Wilson DB
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):297-310. PubMed ID: 26038202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
    Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection.
    Smith JL; Jeng S; McWeeney SK; Hirsch AJ
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology of Glucocorticoid Signaling.
    Vitellius G; Trabado S; Bouligand J; Delemer B; Lombès M
    Ann Endocrinol (Paris); 2018 Jun; 79(3):98-106. PubMed ID: 29685454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt signaling inhibits adrenal steroidogenesis by cell-autonomous and non-cell-autonomous mechanisms.
    Walczak EM; Kuick R; Finco I; Bohin N; Hrycaj SM; Wellik DM; Hammer GD
    Mol Endocrinol; 2014 Sep; 28(9):1471-86. PubMed ID: 25029241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial comment from Dr Fang to increased expression of CYP17 and CYP11B1 in subclinical Cushing's syndrome due to adrenal adenomas.
    Fang Y
    Int J Urol; 2011 Oct; 18(10):697-9. PubMed ID: 21883494
    [No Abstract]   [Full Text] [Related]  

  • 37. Editorial comment from Dr Ishidoya to increased expression of CYP17 and CYP11B1 in subclinical Cushing's syndrome due to adrenal adenomas.
    Ishidoya S
    Int J Urol; 2011 Oct; 18(10):697. PubMed ID: 21883493
    [No Abstract]   [Full Text] [Related]  

  • 38. MiRNA-194 activates the Wnt/β-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU.
    Peng Y; Zhang X; Ma Q; Yan R; Qin Y; Zhao Y; Cheng Y; Yang M; Wang Q; Feng X; Huang Y; Huang W; Zhao Z; Wang L; Wei Y; He Z; Fan X; Li S; Jin Z; Meltzer SJ
    Cancer Lett; 2017 Jan; 385():117-127. PubMed ID: 27810403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SUFU mediates EMT and Wnt/β-catenin signaling pathway activation promoted by miRNA-324-5p in human gastric cancer.
    Peng Y; Zhang X; Lin H; Deng S; Qin Y; Yuan Y; Feng X; Wang J; Chen W; Hu F; Yan R; Zhao Y; Cheng Y; Wei Y; Fan X; Ashktorab H; Smoot D; Li S; Meltzer SJ; Jin Z
    Cell Cycle; 2020 Oct; 19(20):2720-2733. PubMed ID: 33017570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis.
    Sengupta M; Wang BD; Lee NH; Marx A; Kusner LL; Kaminski HJ
    PLoS One; 2018; 13(10):e0205464. PubMed ID: 30308012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.